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Background: Aging is associated with complex and constant remodeling of the immune function, resulting in an
increasing susceptibility to infection and others diseases. The infections caused by Gram-negative microorganisms,
present in nursing homes and hospitals, constitute one of the most common infections in the elderly, and are mainly
combated by innate immune cells. Although the functions of innate immunity seem more preserved during aging
than of adaptive immune mechanisms, two systems operate in an integrated way in the body, so that injury in one
part of the immune system inevitably affects the other as they are part of a defensive network. The aim of this study
was to investigate the in vitro production of proinflammatory (TNF-α, IL-6, IL-1β, CXCL-8 and MCP-1) and anti-
inflammatory (TGF-β and IL-10) cytokines by monocytes, stimulated or not (basal) with lipopolysaccharide, from healthy
young and elderly subjects. By means of PBMCs, we also studied if cytokine profile is altered in these different patient
groups, in the presence of lymphocytes, under the same experimental conditions.
Results: The monocytes from elderly presented higher basal production of TNF-α, MCP-1 and lower of TGF-β than
young monocytes. PBMC showed similar cytokines production, irrespective age or stimulation presence. In the
presence of lymphocytes, the spontaneous production of IL-10 was higher and of TGF-β was lower than monocytes,
regardless of age. After LPS-stimulation, the presence of lymphocytes resulted in increased IL-6, IL-1β, MCP-1 and IL-10
and decreased CXCL-8 and TGF-β in comparison to pure culture of monocytes from young patients. With age, the
same differences were observed, except for CXCL-8 and TGF-β which production was the same between monocytes
and PBMC stimulated with LPS.
Conclusion: These findings reinforce the systemic state of inflamm-aging frequently reported in elderly and considered
a factor of susceptibility to numerous diseases. Still, the cytokine production from just monocytes of the elderly showed
alterations, while in the lymphocyte presence not, suggesting an immunomodulator role of lymphocytes on
monocytes. In addition, the differences between the production patterns by LPS-stimulated PBMC between young and
elderly volunteers can be related with an imbalance in response against Gram-negative bacteria in throughout life.
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In recent decades, the number of elderly has increased
considerably in comparison with young people and there
is a trend towards continuing increase in the twenty-first
century [1]. With these changes in life expectancy of the
population, there has been increasing interest in studies
related to health and quality of life during aging. Advan-
cing age affects various cellular and biological functions,* Correspondence: vanessa@fob.usp.br
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reproduction in any medium, provided the orincluding immune cells [2-9], mostly related to changes
in the equilibrium between cell survival, proliferation
and death. In vitro experiments have shown that absence
of the enzyme telomerase leading to critical shortening
of the protective ends of chromosomes plays a central
role in human cell senescence [10,11]. These changes in
immunosenescence are related to various impairments
such as susceptibility to inflammatory, infectious and
autoimmune diseases, as well as increasing rates of
occurrence of malignancies [1,12-14]. Although these
diseases are usually easily resolved clinically, elderly humans
suffer from complications caused by the individual's alteredtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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elderly is related to predisposition to infectious diseases,
such as caused by Gram-negative microorganisms that are
frequent in nursing homes and hospital settings [15,16]
and mainly combated by innate immune cells. Although
the functions of innate immunity appear to be more pre-
served during aging than the mechanisms developed by
the adaptive immune system [8,17], recent evidence has
shown that most innate immune functions are at least
partly affected during aging [5-7,18-20]. Thus, changes re-
lated to immunosenescence could affect the defense
mechanism as a whole; however, this complex process is
not yet completely understood.
Mononuclear phagocytes cells compromise macrophages
and their monocyte precursors and linage-committed bone
marrow precursors. Both macrophages and peripheral
blood monocytes exhibit morphological heterogeneity and
functional plasticity [21]. Lipopolysaccharide (LPS), an
endotoxin present in the cell wall of Gram-negative bac-
teria and widely used for immunological assay, is recog-
nized by monocyte/macrophage CD14 receptor and toll-
like receptor (TLR) 4-MD2 [22]. These molecular interac-
tions result in the release of different active molecules in
various inflammatory mechanisms including interleukin-1
(IL-1), prostaglandin E2 (PGE2) and tumor necrosis factor
alpha (TNF-α) [22,23], which may be further amplified by
lymphocytes, the main source of important cytokines such
as interferon-gamma (IFN-γ) [24-26]. Peripheral blood
mononuclear cells (PBMC) are composed by monocytes
and lymphocytes and represent an important line of
defense against infection [27-30]. Moreover, human PBMC
culture is a classical and well-known test for evaluation of
the immunological status and for mimicking changes that
occur in infectious lesions and tissue remodeling and
repair after inflammation [21].
During immunosenescence, the role of T lymphocytes is
modified and related mainly to changes in intracellular
signaling pathways [31], with decreased generation of
lymphoid precursors [1,32] and their ability to proliferate
[14]. With advancing age, changes in monocytes are
mainly related to decline in the production of cytokines
such as IL-1, and decrease in tumoricidal activity and
superoxide production [33]. Whereas, monocytes from
aged individuals are associated with increased levels of
circulating interleukin-6 (IL-6) and TNF-α [34], characte-
rizing the state called inflamm-aging, i.e., chronic systemic
inflammation in the elderly [14]. This persistent pro-
inflammatory profile results from high antigenic exposure
throughout life to various microorganisms, including bac-
teria, which can change macromolecules such as deoxy-
ribonucleic acid (DNA) or proteins by oxidation, acylation
or glycosylation. Theses altered molecules can stimulate
the innate immune response, particularly macrophages
via TLRs [35].The better understanding of the changes in immuno-
modulatory interplay between lymphocytes and mono-
cytes during aging and in the cooperation between the
cells in this defense process could elucidate the immune
mechanisms of the elderly associated with increased sus-
ceptibility to infectious diseases, especially those caused
by Gram-negative bacteria [1,14-16,36]. Therefore, this
study investigated the in vitro production of cytokines
TNF-α, IL-6, IL-1β, CXCL-8, MCP-1, TGF-β and IL-10
by PBMC and monocytes from elderly and young volun-
teers after LPS stimulation.
Results
Monocytes from elderly subjects spontaneously produced
more TNF-α, MCP-1 and less TGF-β than young. The
values of cytokine levels detected from monocytes or
PBMC obtained from young or elderly persons were de-
monstrated as median, minimum, maximum and 1th, 3th
quartiles (Tables 1 and 2). The main findings are schema-
tized in Figures 1 and 2. The basal production of TNF-α
and MCP-1 by monocytes from elderly group was higher
than those derived from young individuals. However, the
basal TNF-α production by PBMC showed a fall in elderly,
becoming below than young, although without statistical
difference (Tables 1 and 2). On the other hand, the TGF-β
production without stimulus by monocytes from elderly
was lower than young, while this production was not
detected by PBMC from all subjects (Figure 3).
Although the basal production has been different in
some conditions between young and elderly subjects, LPS-
stimulated monocytes and PBMC from both age groups
produced similar cytokines levels (Figures 1, 3 and 4).
In PBMC, LPS increased more the cytokines produc-
tion than in monocytes. In the most experimental condi-
tions, the LPS caused increase of the cytokine levels in
relation to basal production, except MCP-1 and TGF-β
(Figures 3 and 4).
On the comparative analysis within age groups, in the
presence of lymphocytes, the spontaneous production of
IL-10 was higher and of TGF-β was lower than that of
monocytes, regardless of age. However, LPS-stimulated
PBMC from young or elderly produced more IL-1β, IL-6,
MCP-1 and IL-10 than its respective monocytes (Figures 2,
3 and 4). Besides, the presence of lymphocytes under the
LPS-stimulation resulted in lower production of CXCL-8
and TGF-β in comparison to pure culture of monocytes in
young but not in elderly (Figures 2, 3 and 4).
Discussion
According to the vitro results of this study addressing
cytokines, the monocytes suffer changes throughout life.
The spontaneous production of the TNF-α and MCP-1
by monocytes were increased in aged volunteers com-
pared with those of young individuals. However, the
Table 1 Cytokines production by monocytes or PBMC from young subjects
Cytokines Cellular type Production type Median Minimum Maximum 1th quartile 3th quartile
TNF-α Monocyte Basal 0.0 0.0 24.4 0.0 0.0
LPS 246.6 34.5 1486.5 182.8 97.6
PBMC Basal 2.5 0.0 19.0 0.0 10.4
LPS 341.6 70.8 1165.8 270.3 728.7
IL-6 Monocyte Basal 2.6 0.0 68.1 0.0 8.9
LPS 175.8 50.5 282.0 138.3 186.1
PBMC Basal 0.0 0.0 123.2 0.0 6.4
LPS 139.6 0.0 266.6 116.7 218.2
IL-1β Monocyte Basal 0.0 0.0 0.1 0.0 0.0
LPS 69.6 15.3 173.7 37.5 173.7
PBMC Basal 0.0 0.0 1.0 0.0 0.0
LPS 17.9 0.0 113.8 0.0 31.5
CXCL-8 Monocyte Basal 173.1 48.7 288.8 130 240.1
LPS 279.5 177.3 297.7 252.3 290.9
PBMC Basal 144.8 64.0 215.1 118.6 185.4
LPS 229.8 218.4 305.4 219.8 303.0
MCP-1 Monocyte Basal 6.4 0.0 190.5 0.0 39.8
LPS 48.2 0.0 241.2 0.0 148.4
PBMC Basal 25.9 5.9 412.4 12.2 97.5
LPS 85.0 0.0 415.3 29.1 172.7
TGF-β Monocyte Basal 621.2 621.1 621.4 621.1 621.3
LPS 621.2 621.0 621.6 621.1 621.2
PBMC Basal 51.7 8.9 220.5 25.8 130.9
LPS 567.2 110.2 690.5 223.1 587.9
IL-10 Monocyte Basal 0.0 0.0 5.9 0.0 0.0
LPS 149.3 33.8 654.8 55.4 323.8
PBMC Basal 0.0 0.0 11.8 0.0 0.0
LPS 129.1 47.0 274.1 102.7 195.6
Values showed by median, minimum, maximum, 1th and 3th quartiles obtained by descriptive statistical analysis (Statsoft Software Inc. Tulsa, Ok, USA).
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These immune differences between young and aged
people may represent some aspects of the complex and
constant remodeling of the immune system with advan-
cing age, and contribute with a proinflammatory profile.
Among the variations already found and consistent with
our results is a high TNF-α concentration detected in
the plasma from the elderly [2,37,38], which may be re-
lated to the development of acute and chronic inflam-
matory conditions, carcinogenesis, and autoimmune
diseases [1,12-14]. Irrespective of age, the TNF-α
dysregulation could be associated to several diseases,
such as diabetes type II, rheumatoid arthritis and athero-
sclerosis, among others [39]. Although this change in the
pro-inflammatory profile appears to represent an evolu-
tionary programming to infections resist [40], we not
found a relationship between high levels of TNF-α andincreased protection against the Gram-negative microor-
ganisms in elderly. MCP-1 is a chemokine that regulates
the monocyte and memory T cells migration to sites of
antigen-induced inflammation [27,41,42] and is produced
mainly in response to inflammatory stimulus [43-45]. In-
creased levels of MCP-1 in elderly have been correlated
with the preservation of the memory T cell population and
progression of atherosclerosis [46,47]. Our findings about
the increase on basal production of the MCP-1 in elderly
could represent a systemic alteration in the traffic of the
monocytes and the memory T cells with aging.
Unlike our findings, other studies showed higher levels
of TGF-β from macrophages with aging [48,49]. This
cytokine have a complex and pleiotropic activity, pre-
senting anti-inflammatory action on various cell types,
like mast cells, T cells [50-53] and proinflammatory
function on monocytes, attracting to the local aggression
Table 2 Cytokines production by monocytes or PBMC from elderly subjects
Cytokines Cellular type Production type Median Minimum Maximum 1th quartile 3th quartile
TNF-α Monocyte Basal 0.0 0.0 253.1 0.0 98.4
LPS 489.8 141.6 935.2 378.8 572.2
PBMC Basal 0.0 0.0 98.4 0.0 0.0
LPS 556.1 336.3 1425.1 433.0 694.7
IL-6 Monocyte Basal 0.0 0.0 0.1 0.0 0.1
LPS 363.2 319.8 391.8 329.4 389.6
PBMC Basal 0.0 0.0 0.1 0.0 0.1
LPS 321.1 246.4 489.4 283.2 405.8
IL-1β Monocyte Basal 0.3 0.0 6.8 0.0 3.7
LPS 332.5 276.1 362.3 293.3 358.3
PBMC Basal 0.0 0.0 12.3 0.0 6.1
LPS 323.0 280.0 336.7 299.9 331.4
CXCL-8 Monocyte Basal 59.5 9.3 213.2 11.8 158.9
LPS 202.8 191.1 219.6 193.3 214.8
PBMC Basal 160.1 16.7 197.5 82.3 184.9
LPS 206.5 200.6 224.5 200.7 218.4
MCP-1 Monocyte Basal 4.6 0.0 125.1 0.0 125.1
LPS 999.6 988.0 1039.2 988.0 1039.2
PBMC Basal 314.8 85.2 362.3 85.2 362.3
LPS 994.4 948.2 1013.4 948.2 1013.4
TGF-β Monocyte Basal 0.0 0.0 0.1 0.0 0.1
LPS 23.3 0.0 78.6 0.0 62.6
PBMC Basal 0.0 0.0 0.1 0.0 0.1
LPS 117.0 0.0 397.8 0.0 315.9
IL-10 Monocyte Basal 24.6 0.0 358.6 0.0 271.2
LPS 903.4 447.2 3115.4 701.3 1044.9
PBMC Basal 28.1 0.0 508.2 12.2 52.4
LPS 966.8 490.3 1139.2 649.8 1031.2
Values showed by median, minimum, maximum, 1th and 3th quartiles obtained by descriptive statistical analysis (Statsoft Software Inc. Tulsa, Ok, USA).
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cells [50,54].
Taken together, these results about spontaneous pro-
duction of cytokines, obtained from elderly subjects cor-
roborate the state of inflamm-aging reported in others
works [55-57], which appears to predispose elderly per-
sons to diseases such as Alzheimer's, angina and osteo-
porosis [58-60]. Besides, it could alter the defense
mechanisms against microorganisms [57,61] and reduce
the ability to provide the immediate response to patho-
gens, as well as integrate and influence the acquired im-
mune response [61].
Regarding PBMC, our analyzes showed no significant
difference between the basal production of cytokines
by elderly in relation to young. Already in stimulated-
conditions, PBMC produced higher levels of IL-1β, IL-6,
MCP-1 and IL-10 than matched monocytes, irrespectiveof age. However, CXCL-8 and TGF-β production from
stimulated PBMC was lower than matched monocytes
just in young group. Some trends involving these pro-
duction patterns in elderly also can be highlighted. The
lymphocytes seem to increase the TNF-α and MCP-1
spontaneous production in the elderly, but not in young.
Besides, PBMC from young tend to produce more MCP-
1 and less CXCL-8, whereas in advance of age, these
cells seem to produce more TNF-α and TGF-β. Thereby,
our dates indicate interplay between the two cell types
that may have altered the production of cytokines from
monocytes, suggesting an immunomodulador role of
lymphocytes on monocytes. Also, the modified produc-
tion pattern after LPS stimulus in the presence of the
lymphocytes can indicate a different modulation in the
elderly than in the young, under infectious conditions
caused by Gram-negatives.
Figure 1 Main differences between the cytokines production by monocytes and PBMC from elderly subjects in relation to young. With
increasing age, monocytes showed higher basal production of TNF-α, MCP-1 and lower of TGF-β than monocytes from young.
Figure 2 Influence of lymphocytes presence on cytokines production. Note that with the presence of lymphocytes the spontaneous
production of IL-10 was higher and of TGF-β was lower than that of monocytes, regardless of age. After stimulation with LPS, the presence of
lymphocytes resulted in increased IL-6, IL-1β, MCP-1 and IL-10 and decreased CXCL-8 and TGF-β in comparison to pure culture of monocytes
from of young patients. With age, the same differences were observed, except for CXCL-8 and TGF-β which production was the same between
monocytes and PBMC stimulated with LPS.
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Figure 3 Measurements of the anti-inflammatory cytokines production by blood monocytes (MON) or PBMC from healthy elderly and
young subjects. Peripheral blood was obtained from volunteers, and the cells were purified as described in the Material and Methods section.
Monocytes and PBMC were challenged with LPS (100 ng⁄mL), or not (Basal), for 18 and 24 hours, respectively, and cytokine production was
determined by ELISA. Columns represent the median and error bar the interquartile range. The results were evaluated by Mann–Whitney Rank
Sum Test. In the same subject group, statistical differences are represented by continuous lines (cells stimulated or not) and letters for different cell
types. Asterisks indicate statistical difference between groups of subjects (p values - *0,0016; a and b 0,0039; c 0,0159; d 0,0010, e, f and g <0.0001).
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acterized in lymphocytes with aging. Among them is the
variation in lymphocyte population in PBMC. Whereas
PBMC from young subjects presents 40,6% of the naïve,
36,6% of the memory and 16,8% of the effector/cytotoxic
T cells, in elderly, the lymphocyte population more nu-
merous is of the memory CD8+ T cells (54%) with great
reduction on naïve T cells population (3,6%), [62,63].
Thus, despite the phenomena of immunosenescence being
more related to the cells of the specific immunity system
[8,17], the findings of the present study may represent an
important change in innate immunity cells from the eld-
erly, modulated by cells of the specific immunity system,
strengthening the hypothesis that the interaction between
cells is an important step affected during remodeling
of the immune system in advancing age. Studies on
immunosenescence have shown controversies, including a
decreased production of interleukin-12 (IL-12) by the
monocytes of elderly persons in comparison with those of
young persons, and similar production of IL-10 by mono-
cytes from young or elderly persons [2,33,34,64-66]. The
results of the present study also revealed similar levels of
IL-10 produced by monocytes from young and elderly per-
sons, unlike TNF-α. Higher IL-10 production by PBMC
compared with isolated monocytes was expected, since
lymphocytes are major producers of IL-10. Thus, we tend
to believe that the most important alterations observed in
the present study could be attributed to monocytes, par-
ticularly in the presence of interaction with lymphocytes.
Other alterations in T cell populations in the elderly
[67-69] cannot be ruled out. Further studies will be needed
for better clarification of the molecular mechanisms in-
volved in interaction process between immune cells and
pathogens, in the elderly.Conclusions
In summary, it was found that in vitro monocytes from
aged volunteers spontaneously produced more TNF-α,
MCP-1 and less TGF-β in comparison with those from
young persons, corroborating the state of inflamm-aging
capable of predisposing persons to numerous diseases.
However, in presence of lymphocyte the cytokines levels
were equal between age groups, even after LPS challenge,
suggesting an immunomodulador role of lymphocytes on
monocytes. Still, after LPS challenge, the pattern of cyto-
kines production in presence of lymphocyte was different
between age groups, which may suggest an imbalance in
the response against Gram-negative bacteria. Thus, our
data may indicate that cooperation between lymphocytes
and monocytes from peripheral blood can decrease a basal
state of inflammation present the elderly. However in in-
fectious conditions, this modulation can be altered and
lead to a lower monocyte recruitment, proliferation and
differentiation of other cell types in elderly.
Methods
Sample population
Elderly and young adults were recruited from the Bauru
School of Dentistry, University of São Paulo (USP), and
enrolled in the study. Immunocompromised subjects were
excluded, including individuals with human immunodefi-
ciency virus infection (HIV), diabetes mellitus requiring
medication, and those taking immunomodulating medica-
tions. Subjects who were pregnant, smokers and those
under treatment with antipsychotic drugs were also ex-
cluded. This study was approved by the Ethics committee
at the USP (Protocol No.100/2008, 051/2008 and 172/
2009). Informed consent was obtained from all volunteers
in compliance with Resolution 196/96 of the National
Figure 4 Measurements of the proinflammatory cytokines production by blood monocytes (MON) or PBMC from healthy elderly and
young subjects. Peripheral blood was obtained from volunteers, and the cells were purified as described in the Material and Methods section.
Monocytes and PBMC were challenged with LPS (100 ng⁄mL), or not (Basal), for 18 and 24 hours, respectively, and cytokine production was
determined by ELISA. Columns represent the median and error bar the interquartile range. The results were evaluated by Mann–Whitney Rank
Sum Test. In the same subject group, statistical differences are represented by continuous lines (cells stimulated or not) and letters for different
cell types. Asterisks indicate statistical difference between groups of subjects (p values - *0,0487; a 0,0029; b 0,0068; c 0,0061; d 0,0195; e 0,0180;
** 0,0399; f 0,0089; g 0,0098).
Pinke et al. Immunity & Ageing 2013, 10:22 Page 7 of 10
http://www.immunityageing.com/content/10/1/22Council of Health. The inclusion criteria comprised
healthy subjects in ranging from 20 to 50 years old
(young) and from 60 to 85 years old (elderly) [70].
PBMC isolated
PBMC were obtained by centrifugation of heparinized
venous blood over Histopaque 1083 gradients (Sigma-
Aldrich, St. Louis, MO, USA) (400 × g for 28 minutes).
The cell suspensions recovered at the interface were
washed and resuspended in complete medium (RPMI
1640 supplemented with 10% heat-inactivated fetal bovine
serum, 100 U/mL penicillin and 100 μg/mL streptomycin).
Cell viability, as determined by 0.2% trypan blue dye exclu-
sion, was > 95% in all experiments. PBMC were countedwith the Türk dye staining, and suspended in complete
medium at a concentration of 1×106 PBMC/mL.
Monocytes isolated
To obtain the monocyte (MON) suspension, PBMC
were isolated as previously described. The monocytes
were counted using neutral red (0.02%), and were
suspended in complete medium at a concentration of
1×106 monocytes/mL. After this, were distributed (1.0 mL/
well) in 24-well plates with a flat-bottomed coverslip in
each well to allow adherence of monocytes and immuno-
fluorescence testing on the glass coverslips. After incuba-
tion for 2 h at 37°C in a humidified atmosphere of 5%
CO2, non-adherent cells were removed by aspiration and
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medium. Cell viability was assessed by morphological
analysis of the cells on coverslips with marking using the
anti-CD14-FITC and labeling of the cell nucleus via
DAPi. Over 98% of viable cells were adherent monocytes
that had intensely expressed the CD14 receptor, and
were morphologically viable.
Cell challenge with lipopolysaccharide (LPS)
Monocytes and PBMC were incubated with (LPS) or
without (Basal) LPS of Escherichia coli O55B5 (Sigma-
Aldrich, St. Louis, MO, USA) (100 ng/mL - Mon; 1 ng/
mL-PBMC) for 18 and 24 h, respectively, at 37°C in 5%
CO2. Culture supernatants were harvested and stored
at −80°C until assayed.
Quantification of cytokines
Cytokine concentrations were determined in cell-free su-
pernatants obtained after 24 h PBMC cultures and 18h
monocyte cultures, with or without LPS. The method uti-
lized was enzyme-linked immunosorbent assay (ELISA),
using BD OptEIA™ kits (BD Biosciences) for TNF-α, IL-6,
IL-1β, CXCL8, MCP-1, IL-10 and TGF-β. The evalua-
tions were performed according to the manufacturer’s
instructions.
Statistical methods
All dates showed p values of less than 0.05 for the Normality
Test (Shapiro-Wilk) and were considered non-parametric.
For statistical analysis, was utilized the Mann–Whitney
Rank Sum Test with p values <0.05 considered significant.
The software Statistica 11.0 (Statsoft Software Inc. Tulsa,
Ok, USA) was used.
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